Clinical Diabetes 22:139-140, 2004
© American Diabetes Association ®, Inc., 2004
Case Study: Atropine Ophthalmic Administration Unmasking Undiagnosed Diabetic Gastroparesis
Roger Kenneth Eagan, MD and
Pninit Varol, MD
| The first 20% of the full text of this article appears below. |
 |
Presentation
|
|---|
R.R. is a 62-year-old white man with glaucoma and long-standing type 2
diabetes complicated by peripheral neuropathy and retinopathy. He presented to
the emergency room with persistent nausea and vomiting. The patient was
admitted with presumed symptomatic glaucoma. Three months earlier, he had
undergone pars plana vitrectomy surgery for a vitreal hemorrhage secondary to
a diabetic tractional retinal detachment. The patient had developed subsequent
neovascular glaucoma and had been instructed to use his ophthalmic medications
to control symptoms.
Several weeks before his emergency room visit, he began to experience left
eye pain. The patient was seen by his ophthalmologist, who diagnosed
increasing intraocular pressure (IOP). The ophthalmologist intensified his
regimen and encouraged the patient to carefully follow the provided regimen.
Soon after, R.R. began to suffer from progressive nausea and vomiting.
At the time of presentation, the patient had been unable to keep solids or
liquids down for several days. He was admitted and treated with intravenous
fluids and promethazine, then discharged after 24 hours with arrangements for
surgery the following week. The following day, he returned with ongoing
intractable nausea and vomiting with opthalmalgia. He underwent a successful
shunt placement to relieve his IOP, which relieved his opthalmalgia. However,
he continued to have severe nausea . . . [Full Text of this Article]
 |
Questions
|
|---|
 |
Commentary
|
|---|
 |
Clinical Pearls
|
|---|

CiteULike Del.icio.us Digg Reddit Technorati What's this?
Copyright © 2004 by the American Diabetes Association.
|
|
|